| Dr Brian Albert Staub, MD | |
|
125 N Franklin Dr, Suite 1, Washington, PA 15301-5892 | |
| (724) 225-6500 | |
| Not Available |
| Full Name | Dr Brian Albert Staub |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 17 Years |
| Location | 125 N Franklin Dr, Washington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033358734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | MT191382 (Pennsylvania) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD441904 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Washington Hospital, The | Washington, PA | Hospital |
| Washington Health System Greene | Waynesburg, PA | Hospital |
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Washington Physician Services | 6103719562 | 84 |
News Archive
Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.
Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.
Obesity rates have increased dramatically in developed countries over the past 40 years - and many people have assumed that food marketing is at least in part to blame. But are people with obesity really more susceptible to food marketing? And if they are, is that a permanent predisposition, or can it change over time?
Future Science Group today announced the publication of a new article in Future Science OA, reporting data demonstrating the possibility of measuring 10 biomarkers relevant to autism spectrum disorder in adult saliva.
› Verified 2 days ago
| Entity Name | Washington Physician Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316917669 PECOS PAC ID: 6103719562 Enrollment ID: O20040209000011 |
News Archive
Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.
Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.
Obesity rates have increased dramatically in developed countries over the past 40 years - and many people have assumed that food marketing is at least in part to blame. But are people with obesity really more susceptible to food marketing? And if they are, is that a permanent predisposition, or can it change over time?
Future Science Group today announced the publication of a new article in Future Science OA, reporting data demonstrating the possibility of measuring 10 biomarkers relevant to autism spectrum disorder in adult saliva.
› Verified 2 days ago
| Entity Name | Centerville Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801877048 PECOS PAC ID: 7214837202 Enrollment ID: O20040427000681 |
News Archive
Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.
Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.
Obesity rates have increased dramatically in developed countries over the past 40 years - and many people have assumed that food marketing is at least in part to blame. But are people with obesity really more susceptible to food marketing? And if they are, is that a permanent predisposition, or can it change over time?
Future Science Group today announced the publication of a new article in Future Science OA, reporting data demonstrating the possibility of measuring 10 biomarkers relevant to autism spectrum disorder in adult saliva.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brian Albert Staub, MD 125 N Franklin Dr, Suite 1, Washington, PA 15301-5892 Ph: (724) 225-6500 | Dr Brian Albert Staub, MD 125 N Franklin Dr, Suite 1, Washington, PA 15301-5892 Ph: (724) 225-6500 |
News Archive
Ever since the mid-1970s when Harvard initiated what is now known as "The Nurses Study" we've been told that white women with waists over 40 inches, raised their risk of early death by 40% vs. their slimmer sisters who maintained waists in the 26 to 27 inch measure.
Laurantis Pharma, a privately held biotechnology company based in Finland, today announced that Lymfactin, adenoviral VEGF-C growth factor therapy, was successful in rebuilding lymphatic vessels in pre-clinical animal models.
Obesity rates have increased dramatically in developed countries over the past 40 years - and many people have assumed that food marketing is at least in part to blame. But are people with obesity really more susceptible to food marketing? And if they are, is that a permanent predisposition, or can it change over time?
Future Science Group today announced the publication of a new article in Future Science OA, reporting data demonstrating the possibility of measuring 10 biomarkers relevant to autism spectrum disorder in adult saliva.
› Verified 2 days ago
Nitin Kapoor, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 470 Johnson Rd, Suite 10, Washington, PA 15301 Phone: 724-223-3816 | |
Dr. Jose Vicente Venero, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 125 N Franklin Dr, Washington, PA 15301 Phone: 724-225-6500 Fax: 724-229-2170 | |
Ralph Schmeltz, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 86 Wellness Way, Washington, PA 15301 Phone: 724-229-3300 Fax: 724-229-0975 | |
Richard Hart, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Park Place, Ste 209, Washington, PA 15301 Phone: 724-229-7570 Fax: 724-229-7571 | |
Sun Scolieri, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 125 N Franklin Dr Ste 1, Washington, PA 15301 Phone: 724-225-6500 Fax: 724-229-2170 | |
Dr. Catheri J. Brennan, CATHERINE J. BRENNAN Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 100 Ridge Ave, Washington, PA 15301 Phone: 724-250-7790 |